| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dementia | 92 | 2023 | 453 | 17.330 |
Why?
|
| Depression | 66 | 2023 | 1715 | 8.290 |
Why?
|
| Veterans | 61 | 2023 | 1641 | 6.300 |
Why?
|
| Depressive Disorder | 44 | 2022 | 557 | 5.760 |
Why?
|
| Anxiety Disorders | 50 | 2019 | 666 | 5.680 |
Why?
|
| Caregivers | 34 | 2023 | 677 | 5.390 |
Why?
|
| Aggression | 23 | 2021 | 252 | 4.680 |
Why?
|
| Homebound Persons | 9 | 2020 | 18 | 4.350 |
Why?
|
| Anxiety | 34 | 2023 | 1179 | 3.810 |
Why?
|
| Mental Health Services | 18 | 2022 | 227 | 3.380 |
Why?
|
| Independent Living | 11 | 2022 | 73 | 3.370 |
Why?
|
| Mental Disorders | 24 | 2022 | 862 | 2.750 |
Why?
|
| Alzheimer Disease | 20 | 2023 | 855 | 2.650 |
Why?
|
| Pain | 18 | 2021 | 1658 | 2.560 |
Why?
|
| Accidental Falls | 5 | 2021 | 142 | 2.510 |
Why?
|
| Aged | 206 | 2023 | 70117 | 2.200 |
Why?
|
| Stress Disorders, Post-Traumatic | 15 | 2021 | 604 | 2.110 |
Why?
|
| Nursing Homes | 7 | 2020 | 99 | 2.100 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 17 | 2022 | 1021 | 2.090 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 7 | 2022 | 134 | 2.060 |
Why?
|
| Poverty | 11 | 2020 | 471 | 2.020 |
Why?
|
| Psychomotor Agitation | 16 | 2012 | 78 | 2.010 |
Why?
|
| Psychotherapy | 7 | 2022 | 247 | 1.850 |
Why?
|
| Telemedicine | 10 | 2021 | 471 | 1.800 |
Why?
|
| United States Department of Veterans Affairs | 15 | 2020 | 605 | 1.740 |
Why?
|
| Psychiatric Status Rating Scales | 41 | 2020 | 901 | 1.730 |
Why?
|
| Aged, 80 and over | 86 | 2023 | 29902 | 1.540 |
Why?
|
| Psychotherapy, Brief | 5 | 2019 | 49 | 1.510 |
Why?
|
| Quality of Life | 29 | 2022 | 4532 | 1.460 |
Why?
|
| Activities of Daily Living | 21 | 2022 | 552 | 1.420 |
Why?
|
| Humans | 275 | 2023 | 261506 | 1.390 |
Why?
|
| Male | 185 | 2023 | 123000 | 1.380 |
Why?
|
| Cooperative Behavior | 5 | 2015 | 313 | 1.340 |
Why?
|
| Primary Health Care | 21 | 2020 | 787 | 1.330 |
Why?
|
| Patient Acceptance of Health Care | 6 | 2019 | 573 | 1.310 |
Why?
|
| Mental Health | 11 | 2023 | 415 | 1.290 |
Why?
|
| Geriatric Assessment | 20 | 2020 | 275 | 1.280 |
Why?
|
| Female | 169 | 2023 | 141928 | 1.230 |
Why?
|
| Antipsychotic Agents | 15 | 2022 | 414 | 1.150 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2023 | 1362 | 1.120 |
Why?
|
| Aging | 8 | 2022 | 1582 | 1.110 |
Why?
|
| United States | 44 | 2022 | 15433 | 1.100 |
Why?
|
| Parkinson Disease | 8 | 2020 | 708 | 1.080 |
Why?
|
| Comorbidity | 32 | 2020 | 2352 | 1.080 |
Why?
|
| Delivery of Health Care | 5 | 2017 | 860 | 1.050 |
Why?
|
| Emergency Service, Hospital | 4 | 2019 | 1148 | 1.050 |
Why?
|
| Needs Assessment | 2 | 2019 | 233 | 1.030 |
Why?
|
| Middle Aged | 112 | 2023 | 86204 | 1.030 |
Why?
|
| Health Services for the Aged | 5 | 2016 | 50 | 1.020 |
Why?
|
| Patient Care Team | 10 | 2019 | 795 | 1.000 |
Why?
|
| Adaptation, Psychological | 13 | 2023 | 764 | 0.990 |
Why?
|
| Pain Management | 5 | 2017 | 668 | 0.960 |
Why?
|
| Health Surveys | 3 | 2019 | 402 | 0.940 |
Why?
|
| Bipolar Disorder | 7 | 2019 | 376 | 0.920 |
Why?
|
| Analgesics | 2 | 2017 | 390 | 0.900 |
Why?
|
| Cognitive Dysfunction | 4 | 2022 | 333 | 0.880 |
Why?
|
| Age Factors | 18 | 2019 | 5377 | 0.840 |
Why?
|
| Psychometrics | 14 | 2021 | 937 | 0.840 |
Why?
|
| Community Mental Health Services | 5 | 2016 | 38 | 0.830 |
Why?
|
| Long-Term Care | 3 | 2018 | 83 | 0.830 |
Why?
|
| Medically Underserved Area | 3 | 2018 | 101 | 0.790 |
Why?
|
| Severity of Illness Index | 28 | 2018 | 4320 | 0.790 |
Why?
|
| Stress, Psychological | 6 | 2019 | 1000 | 0.780 |
Why?
|
| Psychotic Disorders | 7 | 2010 | 147 | 0.760 |
Why?
|
| Pain Measurement | 8 | 2017 | 953 | 0.750 |
Why?
|
| Comprehensive Health Care | 2 | 2019 | 49 | 0.750 |
Why?
|
| Central Nervous System Agents | 1 | 2020 | 20 | 0.750 |
Why?
|
| Delivery of Health Care, Integrated | 4 | 2020 | 164 | 0.730 |
Why?
|
| Telephone | 10 | 2019 | 163 | 0.730 |
Why?
|
| Polypharmacy | 1 | 2020 | 57 | 0.720 |
Why?
|
| Randomized Controlled Trials as Topic | 11 | 2022 | 2594 | 0.710 |
Why?
|
| Patient Care Planning | 4 | 2019 | 297 | 0.710 |
Why?
|
| Health Services Misuse | 3 | 2017 | 39 | 0.700 |
Why?
|
| Schizophrenia | 7 | 2019 | 369 | 0.700 |
Why?
|
| Hospitals, Veterans | 14 | 2020 | 397 | 0.690 |
Why?
|
| Antidepressive Agents | 6 | 2016 | 332 | 0.690 |
Why?
|
| Social Participation | 1 | 2019 | 20 | 0.680 |
Why?
|
| Surveys and Questionnaires | 27 | 2021 | 5687 | 0.680 |
Why?
|
| Cholinesterase Inhibitors | 2 | 2017 | 110 | 0.680 |
Why?
|
| Healthy Lifestyle | 1 | 2019 | 44 | 0.680 |
Why?
|
| Hypnotics and Sedatives | 3 | 2016 | 218 | 0.680 |
Why?
|
| Community-Institutional Relations | 2 | 2018 | 42 | 0.680 |
Why?
|
| Treatment Outcome | 42 | 2022 | 32848 | 0.670 |
Why?
|
| Fear | 3 | 2021 | 254 | 0.670 |
Why?
|
| Health Services Needs and Demand | 3 | 2016 | 244 | 0.670 |
Why?
|
| Health Behavior | 2 | 2023 | 603 | 0.670 |
Why?
|
| Longitudinal Studies | 13 | 2019 | 1945 | 0.660 |
Why?
|
| Somatoform Disorders | 3 | 2009 | 61 | 0.660 |
Why?
|
| Ambulatory Care | 6 | 2016 | 554 | 0.660 |
Why?
|
| Referral and Consultation | 5 | 2019 | 899 | 0.650 |
Why?
|
| Respiratory Tract Diseases | 1 | 2019 | 111 | 0.650 |
Why?
|
| Cognition Disorders | 11 | 2011 | 786 | 0.650 |
Why?
|
| Cross-Sectional Studies | 15 | 2022 | 4314 | 0.640 |
Why?
|
| Therapeutic Touch | 1 | 2017 | 5 | 0.640 |
Why?
|
| Psychiatric Department, Hospital | 5 | 2010 | 21 | 0.640 |
Why?
|
| Continuity of Patient Care | 2 | 2011 | 225 | 0.640 |
Why?
|
| Counseling | 2 | 2018 | 381 | 0.630 |
Why?
|
| Length of Stay | 6 | 2018 | 1900 | 0.630 |
Why?
|
| Deprescriptions | 1 | 2017 | 24 | 0.620 |
Why?
|
| Self Report | 9 | 2022 | 756 | 0.610 |
Why?
|
| Texas | 20 | 2020 | 6311 | 0.610 |
Why?
|
| Spirituality | 4 | 2018 | 129 | 0.610 |
Why?
|
| Patient Satisfaction | 8 | 2016 | 915 | 0.600 |
Why?
|
| Cultural Competency | 1 | 2018 | 60 | 0.600 |
Why?
|
| Pleasure | 1 | 2017 | 13 | 0.590 |
Why?
|
| Depressive Disorder, Major | 4 | 2018 | 441 | 0.590 |
Why?
|
| Hospitalization | 18 | 2019 | 2083 | 0.590 |
Why?
|
| Cognition | 10 | 2022 | 968 | 0.580 |
Why?
|
| Empathy | 1 | 2017 | 101 | 0.580 |
Why?
|
| Evidence-Based Medicine | 7 | 2016 | 1085 | 0.570 |
Why?
|
| Feasibility Studies | 9 | 2023 | 2292 | 0.550 |
Why?
|
| Heart Failure | 9 | 2019 | 2516 | 0.550 |
Why?
|
| Costs and Cost Analysis | 3 | 2015 | 306 | 0.550 |
Why?
|
| Social Isolation | 3 | 2013 | 64 | 0.540 |
Why?
|
| Behavior Therapy | 3 | 2021 | 298 | 0.540 |
Why?
|
| Minority Groups | 3 | 2018 | 322 | 0.530 |
Why?
|
| Frailty | 4 | 2022 | 113 | 0.520 |
Why?
|
| Professional Competence | 2 | 2014 | 136 | 0.520 |
Why?
|
| Urban Population | 2 | 2014 | 269 | 0.510 |
Why?
|
| Medication Adherence | 1 | 2019 | 492 | 0.500 |
Why?
|
| Personality Assessment | 5 | 2009 | 105 | 0.500 |
Why?
|
| Social Behavior | 1 | 2017 | 306 | 0.500 |
Why?
|
| Students, Medical | 2 | 2018 | 399 | 0.500 |
Why?
|
| Family | 4 | 2017 | 736 | 0.500 |
Why?
|
| Stroke | 3 | 2014 | 1144 | 0.500 |
Why?
|
| Neuropsychological Tests | 19 | 2022 | 1178 | 0.490 |
Why?
|
| Drug Prescriptions | 1 | 2016 | 289 | 0.490 |
Why?
|
| Interviews as Topic | 8 | 2015 | 497 | 0.480 |
Why?
|
| Interdisciplinary Communication | 2 | 2013 | 280 | 0.480 |
Why?
|
| Health Personnel | 3 | 2022 | 625 | 0.470 |
Why?
|
| Frail Elderly | 6 | 2022 | 118 | 0.470 |
Why?
|
| Sleep Wake Disorders | 2 | 2021 | 348 | 0.470 |
Why?
|
| Health Promotion | 1 | 2018 | 502 | 0.460 |
Why?
|
| Geriatrics | 6 | 2016 | 98 | 0.460 |
Why?
|
| Friends | 1 | 2013 | 24 | 0.460 |
Why?
|
| Postpartum Period | 1 | 2014 | 259 | 0.460 |
Why?
|
| Diabetes Mellitus | 5 | 2021 | 1054 | 0.450 |
Why?
|
| Community Health Services | 2 | 2013 | 126 | 0.450 |
Why?
|
| Disability Evaluation | 5 | 2018 | 249 | 0.450 |
Why?
|
| Health Services Research | 4 | 2014 | 233 | 0.450 |
Why?
|
| Motor Activity | 4 | 2020 | 693 | 0.430 |
Why?
|
| Technology | 1 | 2013 | 96 | 0.430 |
Why?
|
| Prevalence | 15 | 2020 | 3260 | 0.430 |
Why?
|
| Patient Care Management | 2 | 2016 | 94 | 0.420 |
Why?
|
| Benzodiazepines | 5 | 2022 | 170 | 0.420 |
Why?
|
| Interpersonal Relations | 3 | 2012 | 290 | 0.420 |
Why?
|
| Irritable Mood | 1 | 2011 | 12 | 0.420 |
Why?
|
| Personality Inventory | 5 | 2013 | 178 | 0.410 |
Why?
|
| Health Services | 4 | 2012 | 105 | 0.410 |
Why?
|
| Program Development | 4 | 2012 | 261 | 0.410 |
Why?
|
| Attitude to Death | 2 | 2009 | 100 | 0.400 |
Why?
|
| Sick Role | 3 | 2009 | 64 | 0.400 |
Why?
|
| Chronic Pain | 1 | 2015 | 238 | 0.400 |
Why?
|
| Wounds and Injuries | 3 | 2019 | 399 | 0.400 |
Why?
|
| Mental Competency | 8 | 2009 | 62 | 0.400 |
Why?
|
| Exercise | 1 | 2019 | 1183 | 0.400 |
Why?
|
| Risk Factors | 18 | 2019 | 17523 | 0.400 |
Why?
|
| Hypertension | 3 | 2012 | 1503 | 0.390 |
Why?
|
| Financing, Personal | 1 | 2011 | 19 | 0.390 |
Why?
|
| Self-Assessment | 3 | 2009 | 96 | 0.390 |
Why?
|
| Practice Guidelines as Topic | 4 | 2017 | 2403 | 0.380 |
Why?
|
| Incidence | 10 | 2020 | 5673 | 0.380 |
Why?
|
| Religion | 3 | 2018 | 91 | 0.380 |
Why?
|
| Antihypertensive Agents | 2 | 2012 | 395 | 0.370 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2019 | 787 | 0.370 |
Why?
|
| Personality Disorders | 4 | 2009 | 164 | 0.370 |
Why?
|
| Health Care Costs | 2 | 2015 | 674 | 0.370 |
Why?
|
| Information Dissemination | 1 | 2013 | 272 | 0.370 |
Why?
|
| Disabled Persons | 2 | 2016 | 121 | 0.360 |
Why?
|
| Spouses | 1 | 2011 | 134 | 0.350 |
Why?
|
| Self Concept | 3 | 2005 | 211 | 0.340 |
Why?
|
| Religion and Medicine | 1 | 2009 | 50 | 0.340 |
Why?
|
| Hospitalists | 1 | 2010 | 57 | 0.340 |
Why?
|
| Military Personnel | 2 | 2016 | 225 | 0.340 |
Why?
|
| Remote Consultation | 1 | 2009 | 37 | 0.340 |
Why?
|
| Reproducibility of Results | 20 | 2021 | 6009 | 0.340 |
Why?
|
| Coronary Disease | 2 | 2013 | 764 | 0.340 |
Why?
|
| Socioeconomic Factors | 7 | 2016 | 1225 | 0.330 |
Why?
|
| Phototherapy | 1 | 2009 | 75 | 0.330 |
Why?
|
| Personal Autonomy | 4 | 2009 | 212 | 0.330 |
Why?
|
| Patients | 1 | 2011 | 245 | 0.320 |
Why?
|
| Diagnostic Errors | 3 | 2020 | 509 | 0.320 |
Why?
|
| Academic Medical Centers | 2 | 2010 | 672 | 0.320 |
Why?
|
| Wearable Electronic Devices | 5 | 2021 | 105 | 0.320 |
Why?
|
| Arthritis | 1 | 2009 | 139 | 0.320 |
Why?
|
| Valproic Acid | 4 | 2017 | 263 | 0.310 |
Why?
|
| Chronic Disease | 6 | 2019 | 1819 | 0.310 |
Why?
|
| Hepatitis C, Chronic | 3 | 2007 | 451 | 0.300 |
Why?
|
| Adult | 31 | 2023 | 77950 | 0.300 |
Why?
|
| Predictive Value of Tests | 7 | 2015 | 4892 | 0.300 |
Why?
|
| Pilot Projects | 10 | 2020 | 2803 | 0.300 |
Why?
|
| Antidepressive Agents, Tricyclic | 2 | 2022 | 35 | 0.300 |
Why?
|
| Psychiatry | 3 | 2010 | 307 | 0.290 |
Why?
|
| Models, Organizational | 2 | 2019 | 76 | 0.290 |
Why?
|
| Patient Education as Topic | 2 | 2011 | 748 | 0.280 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2012 | 1209 | 0.280 |
Why?
|
| Social Support | 7 | 2015 | 560 | 0.280 |
Why?
|
| Geriatric Psychiatry | 7 | 2004 | 17 | 0.280 |
Why?
|
| Self Efficacy | 4 | 2018 | 298 | 0.280 |
Why?
|
| Patient Compliance | 6 | 2014 | 667 | 0.280 |
Why?
|
| Career Choice | 1 | 2008 | 232 | 0.270 |
Why?
|
| Alcoholism | 3 | 2007 | 285 | 0.270 |
Why?
|
| Mentors | 1 | 2008 | 203 | 0.270 |
Why?
|
| Rehabilitation | 1 | 2005 | 46 | 0.270 |
Why?
|
| Antiviral Agents | 4 | 2007 | 1230 | 0.270 |
Why?
|
| Professional-Patient Relations | 3 | 2014 | 124 | 0.270 |
Why?
|
| Risperidone | 4 | 2017 | 62 | 0.260 |
Why?
|
| Nursing Staff | 1 | 2005 | 15 | 0.260 |
Why?
|
| Logistic Models | 6 | 2019 | 3441 | 0.260 |
Why?
|
| Documentation | 1 | 2007 | 207 | 0.260 |
Why?
|
| Emergency Services, Psychiatric | 1 | 2005 | 22 | 0.260 |
Why?
|
| Research Design | 3 | 2012 | 1544 | 0.260 |
Why?
|
| Respiration Disorders | 1 | 2005 | 45 | 0.260 |
Why?
|
| Decision Making | 9 | 2013 | 1287 | 0.260 |
Why?
|
| Utilization Review | 4 | 2011 | 48 | 0.250 |
Why?
|
| Delirium | 3 | 2013 | 207 | 0.250 |
Why?
|
| Psychotropic Drugs | 3 | 2019 | 133 | 0.250 |
Why?
|
| Vulnerable Populations | 4 | 2016 | 167 | 0.250 |
Why?
|
| Health Status | 6 | 2012 | 590 | 0.250 |
Why?
|
| Testosterone | 3 | 2005 | 619 | 0.240 |
Why?
|
| Lung Diseases, Obstructive | 2 | 2001 | 46 | 0.240 |
Why?
|
| Fellowships and Scholarships | 1 | 2008 | 390 | 0.240 |
Why?
|
| Self Care | 4 | 2009 | 224 | 0.240 |
Why?
|
| Tobacco Use Cessation | 1 | 2023 | 28 | 0.230 |
Why?
|
| Mental Status Schedule | 7 | 2007 | 60 | 0.230 |
Why?
|
| Retrospective Studies | 27 | 2022 | 37905 | 0.230 |
Why?
|
| Inpatients | 6 | 2013 | 678 | 0.230 |
Why?
|
| Body Weight Maintenance | 1 | 2023 | 4 | 0.230 |
Why?
|
| Interferon-alpha | 1 | 2007 | 889 | 0.230 |
Why?
|
| Dementia, Vascular | 3 | 2010 | 16 | 0.230 |
Why?
|
| Alcohol Drinking | 2 | 2019 | 551 | 0.230 |
Why?
|
| Diabetes Complications | 2 | 2019 | 305 | 0.230 |
Why?
|
| Patient Discharge | 4 | 2010 | 661 | 0.230 |
Why?
|
| Religion and Psychology | 3 | 2014 | 27 | 0.220 |
Why?
|
| Counselors | 1 | 2022 | 18 | 0.220 |
Why?
|
| Follow-Up Studies | 10 | 2017 | 14889 | 0.220 |
Why?
|
| Program Evaluation | 5 | 2017 | 597 | 0.220 |
Why?
|
| Quality of Health Care | 1 | 2007 | 621 | 0.220 |
Why?
|
| Mass Screening | 7 | 2012 | 1509 | 0.220 |
Why?
|
| Serotonin and Noradrenaline Reuptake Inhibitors | 1 | 2022 | 10 | 0.210 |
Why?
|
| Cohort Studies | 11 | 2018 | 9244 | 0.210 |
Why?
|
| REM Sleep Behavior Disorder | 1 | 2021 | 8 | 0.210 |
Why?
|
| Recovery of Function | 1 | 2005 | 703 | 0.210 |
Why?
|
| Androgens | 1 | 2005 | 511 | 0.210 |
Why?
|
| Databases, Factual | 5 | 2016 | 2218 | 0.210 |
Why?
|
| Freedom | 2 | 2000 | 20 | 0.200 |
Why?
|
| Walking Speed | 1 | 2021 | 17 | 0.200 |
Why?
|
| Patient-Centered Care | 2 | 2017 | 294 | 0.190 |
Why?
|
| Problem Behavior | 1 | 2021 | 36 | 0.190 |
Why?
|
| Health Services Accessibility | 5 | 2019 | 761 | 0.190 |
Why?
|
| Proportional Hazards Models | 3 | 2020 | 4988 | 0.190 |
Why?
|
| Awareness | 3 | 2005 | 126 | 0.190 |
Why?
|
| Social Behavior Disorders | 1 | 2000 | 13 | 0.180 |
Why?
|
| Mood Disorders | 4 | 2014 | 163 | 0.180 |
Why?
|
| Accelerometry | 1 | 2020 | 63 | 0.180 |
Why?
|
| Suicidal Ideation | 2 | 2021 | 207 | 0.180 |
Why?
|
| Dizziness | 1 | 2019 | 47 | 0.180 |
Why?
|
| Current Procedural Terminology | 1 | 2019 | 6 | 0.170 |
Why?
|
| Prospective Studies | 11 | 2020 | 12873 | 0.170 |
Why?
|
| Advance Directives | 1 | 2020 | 88 | 0.170 |
Why?
|
| Pandemics | 3 | 2023 | 1559 | 0.170 |
Why?
|
| Electroconvulsive Therapy | 2 | 2018 | 59 | 0.170 |
Why?
|
| Social Media | 1 | 2022 | 203 | 0.170 |
Why?
|
| Neurobehavioral Manifestations | 1 | 1998 | 1 | 0.170 |
Why?
|
| Palliative Care | 2 | 2009 | 2037 | 0.160 |
Why?
|
| Clinical Trials as Topic | 3 | 2021 | 3719 | 0.160 |
Why?
|
| Cerebrovascular Disorders | 1 | 2019 | 142 | 0.160 |
Why?
|
| Reference Standards | 3 | 2013 | 339 | 0.160 |
Why?
|
| Behavioral Symptoms | 1 | 1998 | 32 | 0.160 |
Why?
|
| GABA Agents | 1 | 1998 | 26 | 0.160 |
Why?
|
| Paternalism | 1 | 1997 | 32 | 0.160 |
Why?
|
| Young Adult | 4 | 2019 | 21445 | 0.160 |
Why?
|
| Lithium Carbonate | 1 | 2017 | 21 | 0.160 |
Why?
|
| Medical Records Systems, Computerized | 2 | 2013 | 220 | 0.150 |
Why?
|
| Smoking Cessation | 1 | 2023 | 712 | 0.150 |
Why?
|
| Antimanic Agents | 1 | 2017 | 39 | 0.150 |
Why?
|
| Medicare | 1 | 2022 | 860 | 0.150 |
Why?
|
| Transcranial Direct Current Stimulation | 1 | 2017 | 20 | 0.150 |
Why?
|
| Psychomotor Performance | 2 | 2009 | 233 | 0.150 |
Why?
|
| Rural Population | 2 | 2016 | 281 | 0.150 |
Why?
|
| Walking | 3 | 2021 | 277 | 0.150 |
Why?
|
| Internal-External Control | 2 | 2017 | 110 | 0.150 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2021 | 393 | 0.150 |
Why?
|
| Education | 1 | 2017 | 112 | 0.150 |
Why?
|
| Diagnosis, Differential | 7 | 2019 | 4744 | 0.150 |
Why?
|
| Psychotherapy, Group | 2 | 2007 | 59 | 0.150 |
Why?
|
| Trail Making Test | 1 | 2016 | 6 | 0.150 |
Why?
|
| Geriatric Nursing | 1 | 2016 | 4 | 0.150 |
Why?
|
| Internship and Residency | 1 | 2008 | 1375 | 0.150 |
Why?
|
| Hospitals, Psychiatric | 2 | 1997 | 82 | 0.150 |
Why?
|
| Fractures, Bone | 1 | 2019 | 291 | 0.150 |
Why?
|
| Regression Analysis | 5 | 2018 | 1546 | 0.140 |
Why?
|
| Electronic Health Records | 3 | 2020 | 929 | 0.140 |
Why?
|
| Culturally Competent Care | 1 | 2017 | 42 | 0.140 |
Why?
|
| Licensure | 1 | 2016 | 11 | 0.140 |
Why?
|
| Physicians | 1 | 2005 | 882 | 0.140 |
Why?
|
| Patient Care | 1 | 1997 | 149 | 0.140 |
Why?
|
| Motor Cortex | 1 | 2017 | 117 | 0.140 |
Why?
|
| Treatment Failure | 1 | 2019 | 1391 | 0.140 |
Why?
|
| Community Health Workers | 1 | 2016 | 57 | 0.130 |
Why?
|
| Case-Control Studies | 8 | 2020 | 6100 | 0.130 |
Why?
|
| Myocardial Ischemia | 1 | 2019 | 435 | 0.130 |
Why?
|
| Substance-Related Disorders | 4 | 2005 | 524 | 0.130 |
Why?
|
| Education, Distance | 1 | 2016 | 93 | 0.130 |
Why?
|
| Qualitative Research | 2 | 2015 | 556 | 0.130 |
Why?
|
| Healthcare Disparities | 2 | 2018 | 598 | 0.130 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2020 | 367 | 0.130 |
Why?
|
| Health Care Surveys | 1 | 2016 | 430 | 0.130 |
Why?
|
| Osteoarthritis, Knee | 1 | 2017 | 162 | 0.130 |
Why?
|
| Emergency Medical Services | 1 | 2019 | 429 | 0.130 |
Why?
|
| Cost of Illness | 2 | 2010 | 498 | 0.130 |
Why?
|
| Clomipramine | 1 | 1994 | 5 | 0.130 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2016 | 107 | 0.130 |
Why?
|
| Interoception | 1 | 2014 | 5 | 0.120 |
Why?
|
| Elder Abuse | 2 | 2012 | 24 | 0.120 |
Why?
|
| Home Care Services | 2 | 2016 | 92 | 0.120 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2015 | 151 | 0.120 |
Why?
|
| Outpatients | 4 | 2018 | 462 | 0.120 |
Why?
|
| Anti-Anxiety Agents | 3 | 2010 | 90 | 0.120 |
Why?
|
| Observer Variation | 3 | 2005 | 671 | 0.120 |
Why?
|
| Patient Readmission | 3 | 2013 | 548 | 0.120 |
Why?
|
| Panic Disorder | 1 | 2014 | 46 | 0.120 |
Why?
|
| Hospitals | 1 | 1997 | 485 | 0.120 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2015 | 257 | 0.120 |
Why?
|
| Social Environment | 2 | 2010 | 176 | 0.120 |
Why?
|
| Models, Nursing | 1 | 2013 | 9 | 0.120 |
Why?
|
| Problem Solving | 1 | 2014 | 85 | 0.120 |
Why?
|
| Advisory Committees | 1 | 2014 | 203 | 0.120 |
Why?
|
| Pregnant Women | 1 | 2014 | 162 | 0.120 |
Why?
|
| Adolescent | 5 | 2016 | 31252 | 0.110 |
Why?
|
| Patient Admission | 5 | 2008 | 220 | 0.110 |
Why?
|
| Dreams | 1 | 2013 | 28 | 0.110 |
Why?
|
| Cost-Benefit Analysis | 3 | 2022 | 945 | 0.110 |
Why?
|
| Time Factors | 5 | 2014 | 12926 | 0.110 |
Why?
|
| Dyslipidemias | 1 | 2015 | 235 | 0.110 |
Why?
|
| Legal Guardians | 3 | 2009 | 12 | 0.110 |
Why?
|
| Theft | 1 | 2012 | 5 | 0.110 |
Why?
|
| Personality | 1 | 2013 | 116 | 0.110 |
Why?
|
| Public-Private Sector Partnerships | 1 | 2012 | 26 | 0.110 |
Why?
|
| Fraud | 1 | 2012 | 18 | 0.110 |
Why?
|
| Psychology | 2 | 2010 | 86 | 0.100 |
Why?
|
| Investments | 1 | 2012 | 13 | 0.100 |
Why?
|
| Drug Utilization | 1 | 2013 | 179 | 0.100 |
Why?
|
| Quality Improvement | 1 | 2019 | 851 | 0.100 |
Why?
|
| Models, Statistical | 3 | 2015 | 1171 | 0.100 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 2 | 2019 | 231 | 0.100 |
Why?
|
| Social Welfare | 1 | 2011 | 6 | 0.100 |
Why?
|
| Risk | 4 | 2020 | 1972 | 0.100 |
Why?
|
| Societies | 1 | 2011 | 38 | 0.100 |
Why?
|
| Proxy | 1 | 2011 | 23 | 0.100 |
Why?
|
| Financial Management | 1 | 2011 | 20 | 0.100 |
Why?
|
| Focus Groups | 2 | 2010 | 256 | 0.100 |
Why?
|
| Job Satisfaction | 1 | 2012 | 122 | 0.100 |
Why?
|
| Placebos | 2 | 2017 | 437 | 0.090 |
Why?
|
| Emotions | 2 | 2005 | 562 | 0.090 |
Why?
|
| Combined Modality Therapy | 6 | 2023 | 8865 | 0.090 |
Why?
|
| Risk Assessment | 2 | 2022 | 6869 | 0.090 |
Why?
|
| Analgesics, Opioid | 1 | 2020 | 1371 | 0.090 |
Why?
|
| Narcissism | 1 | 2009 | 7 | 0.090 |
Why?
|
| Physicians, Women | 1 | 2012 | 105 | 0.090 |
Why?
|
| Statistics as Topic | 3 | 2007 | 445 | 0.090 |
Why?
|
| Gait | 2 | 2021 | 165 | 0.090 |
Why?
|
| Urban Health Services | 1 | 2010 | 37 | 0.090 |
Why?
|
| Factor Analysis, Statistical | 2 | 2014 | 356 | 0.090 |
Why?
|
| Sex Factors | 3 | 2012 | 2139 | 0.090 |
Why?
|
| Informed Consent | 3 | 2009 | 419 | 0.090 |
Why?
|
| Smoking | 1 | 2019 | 2440 | 0.090 |
Why?
|
| Advance Care Planning | 1 | 2011 | 86 | 0.090 |
Why?
|
| Rural Health Services | 1 | 2010 | 39 | 0.090 |
Why?
|
| Education, Medical, Continuing | 1 | 2012 | 251 | 0.090 |
Why?
|
| Drug Therapy, Combination | 3 | 2017 | 2315 | 0.090 |
Why?
|
| Drug Tolerance | 4 | 1999 | 114 | 0.090 |
Why?
|
| Mianserin | 1 | 2009 | 3 | 0.090 |
Why?
|
| Family Relations | 1 | 2010 | 88 | 0.090 |
Why?
|
| Mind-Body Therapies | 1 | 2009 | 29 | 0.090 |
Why?
|
| Medical Records | 1 | 2011 | 415 | 0.090 |
Why?
|
| Patient Selection | 4 | 2019 | 2055 | 0.090 |
Why?
|
| Self-Help Groups | 1 | 2009 | 37 | 0.090 |
Why?
|
| Sleep | 3 | 2021 | 413 | 0.090 |
Why?
|
| Models, Psychological | 1 | 2010 | 170 | 0.080 |
Why?
|
| Veterans Health | 1 | 2010 | 181 | 0.080 |
Why?
|
| Specialization | 1 | 2010 | 130 | 0.080 |
Why?
|
| Aftercare | 1 | 2010 | 259 | 0.080 |
Why?
|
| Southeastern United States | 1 | 2008 | 54 | 0.080 |
Why?
|
| Task Performance and Analysis | 3 | 2018 | 136 | 0.080 |
Why?
|
| Hepatitis C | 2 | 2005 | 524 | 0.080 |
Why?
|
| Life Support Care | 1 | 2008 | 50 | 0.080 |
Why?
|
| Phobic Disorders | 1 | 2008 | 43 | 0.080 |
Why?
|
| Patient Participation | 2 | 2009 | 446 | 0.080 |
Why?
|
| Delayed Diagnosis | 1 | 2009 | 144 | 0.080 |
Why?
|
| Clinical Competence | 1 | 2016 | 1270 | 0.080 |
Why?
|
| Neurocognitive Disorders | 4 | 1997 | 69 | 0.080 |
Why?
|
| Attitude to Health | 2 | 2009 | 465 | 0.080 |
Why?
|
| Psychological Tests | 2 | 2005 | 131 | 0.080 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 849 | 0.080 |
Why?
|
| Terminally Ill | 1 | 2008 | 91 | 0.080 |
Why?
|
| Family Practice | 1 | 2007 | 125 | 0.070 |
Why?
|
| Prejudice | 1 | 2007 | 57 | 0.070 |
Why?
|
| Hippocampus | 1 | 2013 | 915 | 0.070 |
Why?
|
| Circadian Rhythm | 1 | 2009 | 330 | 0.070 |
Why?
|
| Hostility | 2 | 2013 | 24 | 0.070 |
Why?
|
| Memory, Short-Term | 1 | 2007 | 160 | 0.070 |
Why?
|
| Interview, Psychological | 2 | 2019 | 98 | 0.070 |
Why?
|
| Community-Based Participatory Research | 2 | 2017 | 56 | 0.070 |
Why?
|
| Comprehension | 3 | 2009 | 120 | 0.070 |
Why?
|
| Stroke Rehabilitation | 1 | 2005 | 61 | 0.070 |
Why?
|
| Nonverbal Communication | 1 | 2004 | 9 | 0.060 |
Why?
|
| Self Disclosure | 1 | 2005 | 34 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 2195 | 0.060 |
Why?
|
| Sensitivity and Specificity | 3 | 2013 | 4971 | 0.060 |
Why?
|
| Gels | 1 | 2005 | 105 | 0.060 |
Why?
|
| Disease Progression | 4 | 2010 | 6682 | 0.060 |
Why?
|
| Administration, Topical | 1 | 2005 | 257 | 0.060 |
Why?
|
| Sickness Impact Profile | 1 | 2005 | 139 | 0.060 |
Why?
|
| Office Visits | 1 | 2005 | 97 | 0.060 |
Why?
|
| Health Status Indicators | 1 | 2005 | 224 | 0.060 |
Why?
|
| Videotape Recording | 1 | 2004 | 74 | 0.060 |
Why?
|
| Health Resources | 1 | 2005 | 168 | 0.060 |
Why?
|
| Age of Onset | 2 | 2010 | 827 | 0.060 |
Why?
|
| Patient Health Questionnaire | 1 | 2023 | 21 | 0.060 |
Why?
|
| Cross-Over Studies | 1 | 2005 | 460 | 0.060 |
Why?
|
| Critical Illness | 1 | 2008 | 714 | 0.060 |
Why?
|
| Anticonvulsants | 2 | 1997 | 431 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2010 | 830 | 0.050 |
Why?
|
| Mental Recall | 2 | 2008 | 171 | 0.050 |
Why?
|
| Diffusion of Innovation | 1 | 2004 | 160 | 0.050 |
Why?
|
| Hepacivirus | 1 | 2005 | 397 | 0.050 |
Why?
|
| Linear Models | 2 | 2011 | 1085 | 0.050 |
Why?
|
| Pyridines | 1 | 2009 | 1244 | 0.050 |
Why?
|
| Hypogonadism | 1 | 2005 | 257 | 0.050 |
Why?
|
| Pregnancy | 1 | 2014 | 7573 | 0.050 |
Why?
|
| Pirenzepine | 1 | 2001 | 9 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2005 | 2307 | 0.050 |
Why?
|
| Latin America | 1 | 2021 | 115 | 0.050 |
Why?
|
| Biomedical Research | 1 | 2008 | 806 | 0.050 |
Why?
|
| Multivariate Analysis | 3 | 2014 | 4298 | 0.050 |
Why?
|
| Prisoners | 1 | 2001 | 34 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2012 | 9180 | 0.050 |
Why?
|
| Ambulatory Care Facilities | 1 | 2023 | 289 | 0.050 |
Why?
|
| Organizational Policy | 1 | 2001 | 73 | 0.050 |
Why?
|
| Statistics, Nonparametric | 1 | 2003 | 980 | 0.050 |
Why?
|
| Stress, Physiological | 1 | 2004 | 492 | 0.050 |
Why?
|
| Alcohol-Related Disorders | 1 | 2000 | 40 | 0.040 |
Why?
|
| Goals | 1 | 2021 | 185 | 0.040 |
Why?
|
| Negativism | 1 | 1999 | 2 | 0.040 |
Why?
|
| Culture | 1 | 1999 | 100 | 0.040 |
Why?
|
| Concept Formation | 2 | 2009 | 32 | 0.040 |
Why?
|
| Prefrontal Cortex | 1 | 2000 | 229 | 0.040 |
Why?
|
| Fatigue | 2 | 2018 | 1239 | 0.040 |
Why?
|
| Virtual Reality | 1 | 2018 | 34 | 0.040 |
Why?
|
| Evidence-Based Practice | 1 | 2019 | 117 | 0.040 |
Why?
|
| Psychopathology | 1 | 1998 | 33 | 0.040 |
Why?
|
| Prognosis | 6 | 2014 | 21713 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 14289 | 0.040 |
Why?
|
| Reference Values | 3 | 2009 | 1099 | 0.040 |
Why?
|
| Social Work | 1 | 1998 | 24 | 0.040 |
Why?
|
| Drug Administration Schedule | 2 | 1994 | 3472 | 0.040 |
Why?
|
| Bioethics | 1 | 1999 | 70 | 0.040 |
Why?
|
| Clonazepam | 1 | 1997 | 5 | 0.040 |
Why?
|
| Diagnosis | 1 | 1997 | 34 | 0.040 |
Why?
|
| Guidelines as Topic | 2 | 2010 | 383 | 0.040 |
Why?
|
| Social Values | 1 | 1997 | 62 | 0.040 |
Why?
|
| Social Responsibility | 1 | 1997 | 92 | 0.040 |
Why?
|
| Electrodes | 1 | 2017 | 116 | 0.040 |
Why?
|
| Evaluation Studies as Topic | 1 | 1997 | 418 | 0.040 |
Why?
|
| Postural Balance | 1 | 2018 | 151 | 0.040 |
Why?
|
| Translating | 1 | 2017 | 45 | 0.040 |
Why?
|
| Proof of Concept Study | 1 | 2016 | 53 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 2 | 2010 | 482 | 0.040 |
Why?
|
| Amnesia | 1 | 2016 | 32 | 0.040 |
Why?
|
| Ethics, Medical | 1 | 2000 | 442 | 0.040 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2005 | 1303 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2017 | 409 | 0.030 |
Why?
|
| Fluoxetine | 1 | 1996 | 43 | 0.030 |
Why?
|
| Social Adjustment | 1 | 1996 | 114 | 0.030 |
Why?
|
| Movement | 1 | 2018 | 556 | 0.030 |
Why?
|
| Neoplasms | 1 | 2021 | 15193 | 0.030 |
Why?
|
| Choice Behavior | 1 | 1997 | 226 | 0.030 |
Why?
|
| Language | 1 | 2017 | 309 | 0.030 |
Why?
|
| Intention | 2 | 2009 | 109 | 0.030 |
Why?
|
| Kidney Neoplasms | 1 | 2008 | 3022 | 0.030 |
Why?
|
| Organizational Culture | 1 | 2014 | 106 | 0.030 |
Why?
|
| Millon Clinical Multiaxial Inventory | 1 | 2013 | 2 | 0.030 |
Why?
|
| Lithium | 1 | 1994 | 71 | 0.030 |
Why?
|
| MMPI | 1 | 2013 | 22 | 0.030 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 1995 | 101 | 0.030 |
Why?
|
| Organ Transplantation | 1 | 1996 | 191 | 0.030 |
Why?
|
| Triglycerides | 1 | 1996 | 603 | 0.030 |
Why?
|
| Safety | 2 | 2009 | 465 | 0.030 |
Why?
|
| Schizophrenic Psychology | 3 | 1999 | 102 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 1999 | 4938 | 0.030 |
Why?
|
| PubMed | 1 | 2013 | 41 | 0.030 |
Why?
|
| Cholesterol | 1 | 1996 | 658 | 0.030 |
Why?
|
| Volunteers | 1 | 2012 | 29 | 0.030 |
Why?
|
| Databases, Bibliographic | 1 | 2012 | 30 | 0.030 |
Why?
|
| Drug Monitoring | 1 | 1994 | 333 | 0.030 |
Why?
|
| Leadership | 1 | 2014 | 254 | 0.030 |
Why?
|
| Professional Autonomy | 1 | 2012 | 35 | 0.030 |
Why?
|
| Housing | 1 | 2012 | 61 | 0.030 |
Why?
|
| Korean War | 1 | 2011 | 1 | 0.030 |
Why?
|
| World War II | 1 | 2011 | 6 | 0.030 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2012 | 45 | 0.030 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1994 | 323 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2017 | 2588 | 0.030 |
Why?
|
| Personal Satisfaction | 1 | 2012 | 140 | 0.020 |
Why?
|
| Washington | 1 | 2010 | 70 | 0.020 |
Why?
|
| Workload | 1 | 2012 | 198 | 0.020 |
Why?
|
| Social Class | 1 | 2012 | 310 | 0.020 |
Why?
|
| House Calls | 1 | 2010 | 39 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2012 | 467 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 2012 | 213 | 0.020 |
Why?
|
| Biomarkers | 1 | 2021 | 5047 | 0.020 |
Why?
|
| Higher Nervous Activity | 1 | 2009 | 2 | 0.020 |
Why?
|
| Volition | 1 | 2009 | 11 | 0.020 |
Why?
|
| Deception | 1 | 2009 | 19 | 0.020 |
Why?
|
| Obesity | 1 | 2022 | 2884 | 0.020 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2010 | 203 | 0.020 |
Why?
|
| Motor Skills | 1 | 2009 | 107 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 1 | 2010 | 543 | 0.020 |
Why?
|
| Perception | 1 | 2010 | 350 | 0.020 |
Why?
|
| Neurology | 1 | 2010 | 113 | 0.020 |
Why?
|
| Eligibility Determination | 1 | 2008 | 77 | 0.020 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2008 | 94 | 0.020 |
Why?
|
| Medically Uninsured | 1 | 2008 | 102 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2013 | 1274 | 0.020 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 1994 | 622 | 0.020 |
Why?
|
| Animals | 1 | 2011 | 59536 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 2012 | 792 | 0.020 |
Why?
|
| Reaction Time | 1 | 2005 | 234 | 0.020 |
Why?
|
| Communication | 1 | 2011 | 876 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2009 | 2316 | 0.020 |
Why?
|
| Demography | 1 | 2005 | 435 | 0.010 |
Why?
|
| Systems Integration | 1 | 2004 | 76 | 0.010 |
Why?
|
| Terminal Care | 1 | 2008 | 447 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 1162 | 0.010 |
Why?
|
| Warfare | 1 | 2001 | 37 | 0.010 |
Why?
|
| Recurrence | 1 | 2009 | 4758 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2004 | 785 | 0.010 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 1999 | 9 | 0.010 |
Why?
|
| Ethical Analysis | 1 | 2000 | 54 | 0.010 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2000 | 305 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 1 | 2000 | 310 | 0.010 |
Why?
|
| Cross-Cultural Comparison | 1 | 1999 | 87 | 0.010 |
Why?
|
| Basal Ganglia Diseases | 1 | 1999 | 29 | 0.010 |
Why?
|
| Discriminant Analysis | 1 | 1998 | 48 | 0.010 |
Why?
|
| Estrogens | 1 | 2002 | 751 | 0.010 |
Why?
|
| Flutamide | 1 | 1997 | 40 | 0.010 |
Why?
|
| Sleep Stages | 1 | 1997 | 78 | 0.010 |
Why?
|
| Medical Indigency | 1 | 1997 | 5 | 0.010 |
Why?
|
| Cerebrovascular Circulation | 1 | 2000 | 471 | 0.010 |
Why?
|
| Leuprolide | 1 | 1997 | 65 | 0.010 |
Why?
|
| Motivation | 1 | 2000 | 499 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 1998 | 1323 | 0.010 |
Why?
|
| Education, Medical | 1 | 1999 | 331 | 0.010 |
Why?
|
| Androgen Antagonists | 1 | 1997 | 411 | 0.010 |
Why?
|
| Memory | 1 | 1997 | 429 | 0.010 |
Why?
|
| Hypercholesterolemia | 1 | 1996 | 259 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 7702 | 0.010 |
Why?
|
| Curriculum | 1 | 1999 | 860 | 0.010 |
Why?
|
| Temporal Lobe | 1 | 1995 | 192 | 0.010 |
Why?
|
| Electrocardiography | 1 | 1999 | 1145 | 0.010 |
Why?
|
| Electroencephalography | 1 | 1995 | 898 | 0.010 |
Why?
|